S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
This Stock Could Go Up 66% or More. (Ad)
3 ETFs for the Conservative Investor to Buy and Hold
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
66,000% upside on tiny biotech? (Ad)
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Markets Are Loving These Stocks 'Firing On All Cylinders'
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
This Stock Could Go Up 66% or More. (Ad)
3 ETFs for the Conservative Investor to Buy and Hold
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
66,000% upside on tiny biotech? (Ad)
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Markets Are Loving These Stocks 'Firing On All Cylinders'
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
This Stock Could Go Up 66% or More. (Ad)
3 ETFs for the Conservative Investor to Buy and Hold
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
66,000% upside on tiny biotech? (Ad)
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Markets Are Loving These Stocks 'Firing On All Cylinders'
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
This Stock Could Go Up 66% or More. (Ad)
3 ETFs for the Conservative Investor to Buy and Hold
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
66,000% upside on tiny biotech? (Ad)
A small venture capital player becomes a symbol in the fight over corporate diversity policies
Markets Are Loving These Stocks 'Firing On All Cylinders'
NASDAQ:NURO

NeuroMetrix (NURO) Stock Forecast, Price & News

$0.69
+0.03 (+4.56%)
(As of 09/20/2023 ET)
Compare
Today's Range
$0.68
$0.72
50-Day Range
$0.66
$0.98
52-Week Range
$0.64
$3.45
Volume
14,024 shs
Average Volume
40,969 shs
Market Capitalization
$5.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NURO stock logo

About NeuroMetrix (NASDAQ:NURO) Stock

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NURO Price History

NURO Stock News Headlines

Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
NeuroMetrix Reports Q2 2023 Business Highlights
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
NeuroMetrix Reports Q1 2023 Financial Results
Why NeuroMetrix (NURO) Stock Is Soaring Today
See More Headlines
Receive NURO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroMetrix and its competitors with MarketBeat's FREE daily newsletter.

NURO Company Calendar

Last Earnings
7/27/2023
Today
9/21/2023
Next Earnings (Estimated)
10/19/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NURO
Employees
27
Year Founded
1996

Profitability

Net Income
$-4,420,000.00
Pretax Margin
-75.17%

Debt

Sales & Book Value

Annual Sales
$8.26 million
Book Value
$3.01 per share

Miscellaneous

Free Float
7,941,000
Market Cap
$5.91 million
Optionable
Not Optionable
Beta
2.28

Social Links

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Shai N. Gozani M.D. (Age 58)
    Ph.D., Founder, Chairman, CEO, Pres & Sec.
    Comp: $437.82k
  • Mr. Thomas T. HigginsMr. Thomas T. Higgins (Age 71)
    Sr. VP, CFO & Treasurer
    Comp: $342.87k
  • Dr. Xuan Kong Ph.D.
    Chief Data Scientist
  • Ms. Susan M. Bell R.N.
    Sr. VP of Population Health & Value Based Care













NURO Stock - Frequently Asked Questions

How have NURO shares performed in 2023?

NeuroMetrix's stock was trading at $1.49 at the beginning of 2023. Since then, NURO stock has decreased by 53.8% and is now trading at $0.6882.
View the best growth stocks for 2023 here
.

Are investors shorting NeuroMetrix?

NeuroMetrix saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 26,100 shares, an increase of 76.4% from the August 15th total of 14,800 shares. Based on an average daily volume of 79,100 shares, the days-to-cover ratio is presently 0.3 days.
View NeuroMetrix's Short Interest
.

When is NeuroMetrix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 19th 2023.
View our NURO earnings forecast
.

How were NeuroMetrix's earnings last quarter?

NeuroMetrix, Inc. (NASDAQ:NURO) posted its quarterly earnings data on Thursday, July, 27th. The medical device company reported ($0.19) EPS for the quarter. The medical device company earned $1.66 million during the quarter. NeuroMetrix had a negative net margin of 75.17% and a negative trailing twelve-month return on equity of 24.38%.

When did NeuroMetrix's stock split?

NeuroMetrix's stock reverse split on the morning of Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What is Shai N. Gozani's approval rating as NeuroMetrix's CEO?

10 employees have rated NeuroMetrix Chief Executive Officer Shai N. Gozani on Glassdoor.com. Shai N. Gozani has an approval rating of 57% among the company's employees. This puts Shai N. Gozani in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NeuroMetrix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroMetrix investors own include Merit Medical Systems (MMSI), Palatin Technologies (PTN), Citigroup (C), Salesforce (CRM), Nokia Oyj (NOK), ReWalk Robotics (RWLK), Aurora Cannabis (ACB), Advanced Micro Devices (AMD) and Vaxart (VXRT).

What is NeuroMetrix's stock symbol?

NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."

How do I buy shares of NeuroMetrix?

Shares of NURO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NeuroMetrix's stock price today?

One share of NURO stock can currently be purchased for approximately $0.69.

How much money does NeuroMetrix make?

NeuroMetrix (NASDAQ:NURO) has a market capitalization of $5.91 million and generates $8.26 million in revenue each year. The medical device company earns $-4,420,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis.

How can I contact NeuroMetrix?

NeuroMetrix's mailing address is 4B GILL STREET WOBURN, MASSACHUSETTS MA, 01801. The official website for the company is www.neurometrix.com. The medical device company can be reached via phone at (781) 890-9989, via email at neurometrix.ir@neurometrix.com, or via fax at 302-636-5454.

This page (NASDAQ:NURO) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -